Factors associated with serum total homocysteine level in type 2 diabetes

Environmental Health and Preventive Medicine

Volumn 13, Issue 3, 2008, Pages 148-155

  Masuda, Yumi ^a   Kubo, Akira ^b   Kokaze, Akatsuki ^c   Yoshida, Masao ^a   Fukuhara, Nobuki ^b   Takashima, Yutaka ^a  

^a KYORIN UNIVERSITY   (Japan)

^b Takanawa Medical Clinic   (Japan)

^c SHOWA UNIVERSITY   (Japan)

Author keywords

Estimated glomerular filtration rate; Homocysteine; Lifestyle; Serum creatinine; Type 2 diabetes mellitus

Indexed keywords

CREATININE; GLUCOSE; HEMOGLOBIN A1C; HOMOCYSTEINE; TRIACYLGLYCEROL;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 49549106901     PISSN: 1342078X     EISSN: 13474715     Source Type: Journal    
DOI: 10.1007/s12199-008-0024-2     Document Type: Article

References (47)

1. MH. Stipanuk 2004 Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine Annu Rev Nutr 24 539 77
2. GN Welch J. Loscalzo 1998 Homocysteine and atherothrombosis N Engl J Med 338 1042 50
3. SR. Maxwell 2000 Coronary artery disease-free radical damage, antioxidant protection and the role of homocysteine Basic Res Cardiol 95 suppl1 165 71
4. N. Weiss 2005 Mechanisms of increased vascular oxidant stress in hyper homocysteinemia and its impact on endothelial function Curr Drug Metab 6 27 36
5. The Homocysteine Studies Collaboration. 2002 Homocysteine, risk of ischemic heart disease, stroke JAMA 288 2015 22
6. JW Eikelboom E Lonn J Genest Jr G Hankey S Yusuf 1999 Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence Ann Intern Med 131 363 75
7. M Soinio J Marniemi M Laakso T Rönnemaa 2004 Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus Ann Intern Med 140 94 100
8. H Iso Y Moriyama S Sato A Kitamura T Tanigawa T Shimamoto 2004 Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese Circulation 109 2766 72
9. R Kawamoto T Kajiwara Y Oka Y. Takagi 2001 An association between plasma homocysteine concentrations and ischemic stroke in elderly Japanese J Atheroscler Thromb 9 121 5
10. J Schneede H Refsum PM. Ueland 2002 Biological and environmental determinants of plasma homocysteine Semin Thromb Hemost 26 263 79
11. H Refsum AD Smith PM. Ueland 2004 Facts and recommendations about total homocysteine determinations: an expert opinion Clin Chem 50 3 32
12. O Stanger W Herrmann K Pietrzik B Fowler J Geisel M Wegel 2004 DACH-LIGA homocysteine e.V.: DACH-LIGA homocysteine (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic disease: guidelines and recommendations Clin Chem Lab Med 42 113 6
13. PF. Jacques 2001 Determinants of plasma total homocysteine concentration in the Framingham offspring cohort Am J Clin Nutr 73 613 21
14. E Diakoumopoulou N Tentolouris E Kirlaki D Perrea E Kitsou N Katsilambros 2005 Plasma homocysteine levels in patients with type 2 diabetes in a Mediterranean population: relation with nutritional and other factors Nutr Metab Cardiovasc Dis 15 109 17
15. LA Kluijtmans JJ Kastelein J Lindemans GH Boers SG Heil HJ Blom 1997 Thermolabile methylenetetrahydrofolate reductase in coronary artery disease Circulation 96 2573 7
16. O Nygård SE Vollset H Refsum I Stensvold A Tverdal G Kvåle 1995 Total plasma homocysteine and cardiovascular risk profile. The Hordaland homocysteine study JAMA 274 1526 33
17. RT Hurst RW. Lee 2003 Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: mechanisms and management Ann Intern Med 139 824 34
18. CS Fox S Coady PD Sorlie D Levy JB Meigs PJ Savage 2004 Trends in cardiovascular complications of diabetes JAMA 292 2495 9
19. H Sone A Katagiri S Ishibashi R Abe Y Saito N Yamada 2002 Effects of lifestyle modifications on patients with type 2 diabetes: the Japan diabetes complications study (JDCS) study design, baseline analysis and three year-interim report Horm Metab Res 34 509 15
20. M Fujishima Y Kiyohara I Kato T Ohmura H Iwamoto T Yoshitake 1996 Diabetes and cardiovascular disease in a prospective population survey in Japan: the Hisayama study Diabetes 45 suppl3 S14 6
21. M Emoto H Kanda T Shoji T Kawagishi M Komatsu Y Nishizawa 2001 Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes Diabetes Care 24 533 8
22. A Mazza E Bossone F Mazza A Distante 2005 Reduced serum homocysteine levels in type 2 diabetes Nutr Metab Cardiovasc Dis 15 118 24
23. KL. Schalinske 2003 Interrelationship between diabetes and homocysteine metabolism: hormonal regulation of cystathionine beta-synthase Nutr Rev 61 136 8
24. AN Elias S. Eng 2005 Homocysteine concentrations in patients with diabetes mellitus-relationship to microvascular and macrovascular disease Diabetes Obes Metab 7 117 21
25. T Masaki F Anan M Anai K Higuchi T Tsubone H Yoshimatsu 2007 Hyperhomocysteinemia is associated with visceral adiposity in Japanese patients with type 2 diabetes mellitus Diabetes Res Clin Pract 77 168 73
26. E Imai M Horio K Nitta K Yamagata K Iseki S Matsuo 2007 Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic Kidney disease Clin Exp Nephrol 11 41 50
27. The expert committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183-97.
28. I Hatakeyama T Maruko Y Ida A Tsuruoka E Maehata 1999 Fundamental and clinical evaluation for glycosylated hemoglobin measurement kit "Determiner HbA1c" using latex agglutination immunoassay Med Pharm 41 1181 6
29. T. Sakurai 1998 Fundamental study on measurement of total cholesterol by ultra violet-end (UV-End) method using cholesterol dehydrogenase (CDH) Jpn J Med Techol 47 747 52
30. Y Shibuya H. Okabe 1995 Triglyceride Nippon Rinsho 53 suppl 606 10
31. Chobanian and the National High Blood Pressure Education Program Coordinating Committee, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206-52.
32. The committee of Japan Diabetes Society for the Diagnostic Criteria of Diabetes Mellitus, Kuzuya T, Kadowaki T, et al. Report of the committee of japan diabetes society on the classification and diagnostic criteria of diabetes mellitus. J Japan Diab Soc. 1999;42:385-404.
33. EK Hoogeveen PJ Kostense C Jakobs LM Bouter RJ Heine CD Stehouwer 1997 Does metformin increase the serum total homocysteine level in non-insulin-dependent diabetes mellitus? J Intern Med 242 389 94
34. MG Wouters MT Moorrees MJ van der Mooren HJ Blom GH Boers TK Eskes 1995 Plasma homocysteine and menopausal status Eur J Clin Invest 25 801 5
35. Y Xiong Y Fu S Fu H. Zhou 2003 Elevated levels of the serum endogenous inhibitor of nitric oxide synthase and metabolic control in rats with streptozotocin-induced diabetes J Cardiovasc Pharmacol 42 191 6
36. C Antoniades D Tousoulis K Marinou C Vasiliadou C Tentolouris C Stefanadis 2006 Asymmetrical dimethylarginine regulates endothelial function in methionine-induced but not in chronic homocysteinemia in humans: effect of oxidative stress and proinflammatory cytokines Am J Clin Nutr 84 781 8
37. J Björck M Hellgren L Råstam U Lindblad 2006 Associations between serum insulin and homocysteine in a Swedish population - a potential link between the metabolic syndrome and hyperhomocysteinemia: the Skaraborg project Metabolism 55 1007 13
38. V Fonseca A Dicker-Brown S Ranganathan W Song RJ Barnard PA Kern 2000 Effects of a high-fat-sucrose diet on enzymes in homocysteine metabolism in the rat Metabolism 49 736 41
39. N Abdella OA Mojiminiyi AO. Akanji 2000 Homocysteine and endogenous markers of renal function in type 2 diabetic patients without coronary heart disease Diabetes Res Clin Pract 50 177 85
40. SP Stabler R Estacio BW Jeffers JA Cohen RH Allen RW Schrier 1999 Total homocysteine is associated with nephropathy in non-insulin-dependent diabetes mellitus Metabolism 48 1096 101
41. B Ozmen D Ozmen N Turgan S Habif I Mutaf O Bayindir 2002 Association between homocysteine and renal function in patients with type 2 diabetes mellitus Ann Clin Lab Sci 32 279 86
42. SH Mudd JR. Poole 1975 Labile methyl balances for normal humans on various dietary regimens Metabolism 24 721 35
43. Davies L, Wilmshurst EG, McElduff A, Gunton J, Clifton-Bligh P, Fulcher GR. 2001 The relationship among homocysteine, creatinine clearance, and albuminuria in patients with type 2 diabetes Diabetes Care 24 1805 9
44. C van Guldener CD. Stehouwer 2003 Homocysteine metabolism in renal disease Clin Chem Lab Med 41 1412 7
45. NA Abdella OA Mojiminiyi AO Akanji MA Moussa 2002 Association of plasma homocysteine concentration in subjects with type 2 diabetes mellitus Acta Diabetol 39 183 90
46. K Nakamura T Okamura T Hayakawa T Kadowaki Y Kita H Ueshima 2006 The NIPPON DATA90 Research Group. Chronic kidney disease is a risk factor for cardiovascular death in a community-based population in Japan: NIPPON DATA90 Circ J 70 954 9
47. CD Agardh E Agardh A Andersson B Hultberg 1994 Lack of association between plasma homocysteine levels and microangiopathy in type 1 diabetes mellitus Scand J Clin Lab Invest 54 637 41